Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
Simona Camorani(National Academies of Sciences, Engineering, and Medicine), Laura Cerchia(National Academies of Sciences, Engineering, and Medicine)
Cited by 93
Related Papers
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
|Theranostics|2017|91
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
|Journal of Experimental & Clinical Cancer Research|2021|82
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2020|70
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells
|Oncotarget|2015|67
Frontiers in Drug Design and Discovery
|Unknown|2006|49